Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients

Archives of Ophthalmology

Volumn 119, Issue 4, 2001, Pages 554-563

  Holbrook, Janet T ^a,d   Meinert, Curtis L ^a   Van Natta, Mark L ^a   Davis, Matthew ^c   Hubbard, Larry ^c   Jabs, Douglas A ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHOTOGRAPHY; PRIORITY JOURNAL; RETINITIS; SAMPLE; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT;

EID: 0035072158     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.119.4.554     Document Type: Article

References (28)

1. A randomized controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS
2. Oral ganciclovir as maintenance therapy for cytomegalovirus retinitis in patients with AIDS
3. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: A randomized controlled trial
4. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: A randomized controlled trial
5. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS
6. Assessment of cytomegalovirus retinitis: Clinical evaluation vs centralized grading of fundus photographs
7. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial, 4: Visual outcomes
8. Surrogate endpoints in clinical trials
9. Surrogate endpoints: A basis for a rationale approach
10. Criteria for the validation of surrogate endpoints in randomized experiments
11. Statistical validation of intermediate end-points for chronic diseases
12. Mortality in patients with acquired immune deficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis
13. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The Cytomegalovirus Retreatment Trial
14. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome
15. Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial, 1: Rationale, design, and methods
16. The validity and reliability of photographic documentation of proliferative vitreoretinopathy
17. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy
18. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodefiency syndrome
19. New visual acuity charts for clinical research
20. Photocoagulation treatment for proliferative retinopathy: The second report of the Diabetic Retinopathy Study findings
21. Nonparametric estimation from incomplete observations
22. The robust inference for the Cox proportional hazards model
23. Longitudinal data analysis using generalized linear model
24. Nomogram for calculation of the number patients need for a clinical trial with survival as an endpoint
25. Power and sample size calculation: A review of computer programs